A. Greijer
Journal of Clinical Pathology · 2004
A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Whom A. Greijer trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts A. Greijer overall
Papers from A. Greijer's perspective
Ordered by how strongly the researchers A. Greijer trusts endorse each paper. Same corpus, a different order for every researcher.
- Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor Protein* (Journal of Biological Chemistry)
- Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. (Genes & Development)
- Hypoxia — a key regulatory factor in tumour growth (Nature Reviews. Cancer)
- Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation (Molecular and Cellular Biology)
- Differentiating the functional role of hypoxia‐inducible factor (HIF)‐1α and HIF‐2α (EPAS‐1) by the use of RNA interference: erythropoietin is a HIF‐2α target gene in Hep3B and Kelly cells
- Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. (Journal of the National Cancer Institute)
- Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation (Science)
- Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. (Cancer Cell)
- Early expression of angiogenesis factors in acute myocardial ischemia and infarction. (New England Journal of Medicine)
- A MicroRNA Signature of Hypoxia (Molecular and Cellular Biology)
Their papers
- The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis (2004) — 777 citations